argenx SE (ARGX)
USD 548.93
(-0.19%)
USD 548.93
(-0.19%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 444.95 Million USD | 38.8% |
| 2022 | 320.56 Million USD | 1.43% |
| 2021 | 316.05 Million USD | -47.91% |
| 2020 | 606.75 Million EUR | 41.58% |
| 2019 | 428.56 Million EUR | 835.17% |
| 2018 | 45.82 Million EUR | 47.05% |
| 2017 | 31.16 Million EUR | -30.11% |
| 2016 | 44.59 Million EUR | 369.65% |
| 2015 | 9.49 Million EUR | -7.36% |
| 2014 | 10.24 Million EUR | 124.36% |
| 2013 | 4.56 Million EUR | -27.24% |
| 2012 | 6.27 Million EUR | 55.3% |
| 2011 | 4.04 Million EUR | 99.25% |
| 2010 | 2.02 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 534.31 Million USD | 0.0% |
| 2024 Q1 | - USD | -100.0% |
| 2023 Q2 | 335.74 Million USD | 0.0% |
| 2023 FY | 444.95 Million USD | 38.8% |
| 2023 Q4 | 444.95 Million USD | 0.0% |
| 2023 Q3 | - USD | -100.0% |
| 2023 Q1 | - USD | -100.0% |
| 2022 Q2 | 279.01 Million USD | 0.0% |
| 2022 FY | 320.56 Million USD | 1.43% |
| 2022 Q4 | 320.56 Million USD | 0.0% |
| 2022 Q3 | - USD | -100.0% |
| 2021 Q4 | 316.05 Million USD | 0.0% |
| 2021 Q2 | 261.08 Million USD | 0.0% |
| 2021 FY | 316.05 Million USD | -47.91% |
| 2020 Q2 | 456.61 Million EUR | 0.0% |
| 2020 FY | 606.75 Million EUR | 41.58% |
| 2020 Q4 | 606.75 Million EUR | 0.0% |
| 2019 Q4 | 382.59 Million EUR | 0.0% |
| 2019 FY | 428.56 Million EUR | 835.17% |
| 2019 Q2 | 390.84 Million EUR | 0.0% |
| 2018 Q2 | 31.28 Million EUR | 0.0% |
| 2018 Q4 | 45.82 Million EUR | 0.0% |
| 2018 FY | 45.82 Million EUR | 47.05% |
| 2017 Q2 | 40.3 Million EUR | 0.0% |
| 2017 Q4 | 31.16 Million EUR | 0.0% |
| 2017 FY | 31.16 Million EUR | -30.11% |
| 2016 FY | 44.59 Million EUR | 369.65% |
| 2016 Q4 | 44.59 Million EUR | 0.0% |
| 2016 Q2 | 46.64 Million EUR | 0.0% |
| 2015 Q2 | 11.59 Million EUR | 0.0% |
| 2015 FY | 9.49 Million EUR | -7.36% |
| 2015 Q4 | 9.49 Million EUR | 0.0% |
| 2014 Q1 | 3.66 Million EUR | -19.7% |
| 2014 Q2 | 14.12 Million EUR | 285.0% |
| 2014 Q4 | 10.24 Million EUR | 0.0% |
| 2014 FY | 10.24 Million EUR | 124.36% |
| 2013 FY | 4.56 Million EUR | -27.24% |
| 2013 Q4 | 4.56 Million EUR | 0.0% |
| 2012 FY | 6.27 Million EUR | 55.3% |
| 2011 FY | 4.04 Million EUR | 99.25% |
| 2010 FY | 2.02 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 272.28 Million USD | -63.413% |
| Jaguar Health, Inc. | 45.86 Million USD | -870.111% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1076.745% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -4452.394% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 89.015% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -240.419% |
| ContextLogic Inc. | 206 Million USD | -115.996% |
| MiMedx Group, Inc. | 96.33 Million USD | -361.903% |
| MEI Pharma, Inc. | 8.35 Million USD | -5225.566% |
| AlloVir, Inc. | 45.01 Million USD | -888.451% |
| Novavax, Inc. | 2.57 Billion USD | 82.702% |
| Aptorum Group Limited | 5.25 Million USD | -8364.394% |
| Ardelyx, Inc. | 130.76 Million USD | -240.273% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 6.99% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3575.853% |
| Vaxcyte, Inc. | 167.44 Million USD | -165.723% |
| Precigen, Inc. | 41.64 Million USD | -968.464% |
| Pharming Group N.V. | 244.07 Million USD | -82.302% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 8.559% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3632.184% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -205.035% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -248.186% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -12508.82% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -6634.255% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -6634.255% |
| Bicycle Therapeutics plc | 224.41 Million USD | -98.274% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -439.773% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -6598.043% |
| Acelyrin, Inc. | 86.35 Million USD | -415.27% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2994.45% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -4594.071% |
| Senti Biosciences, Inc. | 52.57 Million USD | -746.381% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -546.947% |
| AbCellera Biologics Inc. | 335.77 Million USD | -32.514% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -22648.006% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -241.718% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -96.159% |
| Chimerix, Inc. | 19.74 Million USD | -2153.487% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -4650.198% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1433.521% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1164.888% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1059.542% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1197.914% |
| Alkermes plc | 933.53 Million USD | 52.337% |
| Fortress Biotech, Inc. | 165.93 Million USD | -168.141% |
| Fortress Biotech, Inc. | 165.93 Million USD | -168.141% |
| Agenus Inc. | 462.29 Million USD | 3.752% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -522.483% |
| Dyadic International, Inc. | 2.34 Million USD | -18909.711% |
| ImmuCell Corporation | 18.81 Million USD | -2264.871% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2635.971% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1476.387% |
| Lantern Pharma Inc. | 2.73 Million USD | -16140.972% |
| Immix Biopharma, Inc. | 3.72 Million USD | -11855.318% |
| Incyte Corporation | 1.59 Billion USD | 72.056% |
| IO Biotech, Inc. | 17.55 Million USD | -2434.467% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1133.987% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -12509.399% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -851.991% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -193.674% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -18098.405% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1517.357% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -89.169% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 10.022% |
| NextCure, Inc. | 14.99 Million USD | -2866.933% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -10908.189% |
| Onconetix, Inc. | 23.18 Million USD | -1819.473% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -6563.936% |
| Opthea Limited | 264.6 Million USD | -68.159% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1237.831% |
| PureTech Health plc | 125.58 Million USD | -254.308% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -826.557% |
| Seer, Inc. | 39.36 Million USD | -1030.321% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -34146.995% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -791.15% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -33215.588% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -4871.52% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -95.63% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -28.014% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -241.385% |
| ChromaDex Corporation | 26.5 Million USD | -1578.554% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -3976.883% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -513.159% |
| CRISPR Therapeutics AG | 346.76 Million USD | -28.314% |
| Precision BioSciences, Inc. | 140.92 Million USD | -215.747% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -222.896% |
| Innoviva, Inc. | 568.55 Million USD | 21.74% |
| Summit Therapeutics Inc. | 125.25 Million USD | -255.23% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -619.59% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1534.167% |
| ESSA Pharma Inc. | 3.49 Million USD | -12630.814% |
| GlycoMimetics, Inc. | 6.9 Million USD | -6346.627% |
| GT Biopharma, Inc. | 6.63 Million USD | -6608.141% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -68.293% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -429.54% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1537.716% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -13693.624% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -503.184% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2714.596% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -3930.468% |
| Soligenix, Inc. | 7.27 Million USD | -6016.246% |
| Century Therapeutics, Inc. | 175.94 Million USD | -152.898% |
| Kura Oncology, Inc. | 51.66 Million USD | -761.273% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -266.873% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -10665.812% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -6627.559% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -76.15% |
| Autolus Therapeutics plc | 263.9 Million USD | -68.601% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -4144.906% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -400.727% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -848.743% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -26.1% |
| GRI Bio, Inc. | 2.69 Million USD | -16397.998% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -54860.381% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1331.125% |
| IGM Biosciences, Inc. | 220.17 Million USD | -102.088% |
| INmune Bio, Inc. | 18.86 Million USD | -2258.981% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -73.484% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1570.123% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -16268.085% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -13464.479% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -661.186% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -362.724% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -68.074% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 45.937% |
| Verastem, Inc. | 71.18 Million USD | -525.063% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -804.813% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1053.38% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -809.325% |
| Histogen Inc. | 5.69 Million USD | -7710.269% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -10045.715% |
| Surrozen, Inc. | 8.14 Million USD | -5362.873% |
| Organovo Holdings, Inc. | 2.74 Million USD | -16091.812% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -141668.252% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -691.307% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2594.713% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -770.694% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -53711.156% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -251.115% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -4014.739% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -194.886% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -16965.291% |
| Apollomics, Inc. | 14.15 Million USD | -3043.863% |
| Amarin Corporation plc | 279.58 Million USD | -59.146% |
| Mesoblast Limited | 188.79 Million USD | -135.676% |
| Turnstone Biologics Corp. | 14.14 Million USD | -3044.975% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -146.118% |
| Synaptogenix, Inc. | 5.52 Million USD | -7946.903% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -6593.005% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -161.57% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5099.731% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -25218.81% |
| Exelixis, Inc. | 678.44 Million USD | 34.416% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1766.249% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -171.236% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 25.119% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4066.128% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -27304.941% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1043.04% |
| Gritstone bio, Inc. | 125.91 Million USD | -253.363% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2931.827% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -8644.029% |
| Avid Bioservices, Inc. | 275.66 Million USD | -61.408% |
| Insmed Incorporated | 1.66 Billion USD | 73.224% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -5683.073% |
| MediWound Ltd. | 27.18 Million USD | -1536.631% |
| OmniAb, Inc. | 87.4 Million USD | -409.097% |
| Alector, Inc. | 487.66 Million USD | 8.76% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -10.285% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2314.931% |
| Zai Lab Limited | 240.17 Million USD | -85.26% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 29.379% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1422.397% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -367.99% |
| Immunic, Inc. | 25.36 Million USD | -1653.985% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -542.658% |
| Veracyte, Inc. | 93.71 Million USD | -374.771% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -16904.456% |
| FibroGen, Inc. | 585.72 Million USD | 24.035% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2459.691% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -68031.58% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -7767.639% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 94.188% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -5327.556% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -429.565% |
| TG Therapeutics, Inc. | 169.08 Million USD | -163.152% |
| Galecto, Inc. | 5.89 Million USD | -7446.659% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -5271.21% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 83.007% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1443.789% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3425.481% |
| XBiotech Inc. | 8.39 Million USD | -5198.928% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2931.827% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -736.689% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -22.54% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1555.077% |
| Theravance Biopharma, Inc. | 169 Million USD | -163.278% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 63.397% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 11.086% |
| Vaxxinity, Inc. | 30.94 Million USD | -1337.923% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 54.246% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -7277.601% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 40.294% |
| NexImmune, Inc. | 5.08 Million USD | -8651.587% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -119705.651% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -14370.667% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 93.739% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -8533.07% |
| Scopus BioPharma Inc. | 7.45 Million USD | -5868.944% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1592.215% |
| Ainos, Inc. | 7.39 Million USD | -5917.549% |
| Pluri Inc. | 34.11 Million USD | -1204.383% |
| Prothena Corporation plc | 135.01 Million USD | -229.552% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -83.03% |
| Celularity Inc. | 102.92 Million USD | -332.289% |
| Rallybio Corporation | 9.43 Million USD | -4615.462% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1720.213% |
| MeiraGTx Holdings plc | 319.99 Million USD | -39.051% |
| Omeros Corporation | 403.25 Million USD | -10.341% |
| Humacyte, Inc. | 114.67 Million USD | -288.004% |
| Immunocore Holdings plc | 228.15 Million USD | -95.019% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -9027.2% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -479.816% |
| Blueprint Medicines Corporation | 918.64 Million USD | 51.564% |
| CalciMedica, Inc. | 4.02 Million USD | -10946.45% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2449.57% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -188.661% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -418.488% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -60.174% |
| Pulmatrix, Inc. | 15.96 Million USD | -2687.39% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2720.966% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1708.303% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -77.407% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -776.129% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 63.247% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1299.965% |
| Nutriband Inc. | 1.07 Million USD | -41140.445% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -4084.623% |
| Vor Biopharma Inc. | 59.1 Million USD | -652.827% |
| Roivant Sciences Ltd. | 773.95 Million USD | 42.509% |
| Evogene Ltd. | 17.99 Million USD | -2373.324% |
| ProKidney Corp. | 29.21 Million USD | -1422.97% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -518.168% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -63015.139% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 76.444% |
| CorMedix Inc. | 11.91 Million USD | -3633.585% |
| BioLineRx Ltd. | 50.7 Million USD | -777.581% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -197.708% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -403.105% |
| Atai Life Sciences N.V. | 49.16 Million USD | -805.071% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1328.308% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2377.18% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -257.0% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -7769.667% |
| MediciNova, Inc. | 3.89 Million USD | -11333.764% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2334.22% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -29479.768% |
| GeoVax Labs, Inc. | 3.51 Million USD | -12541.081% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -12.005% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1349.824% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 83.652% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2687.564% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1326.079% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -658.215% |
| Absci Corporation | 58.3 Million USD | -663.157% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2235.946% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1287.783% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -502.996% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -408.614% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1217.593% |
| Allakos Inc. | 74.79 Million USD | -494.91% |
| Imunon, Inc. | 8.53 Million USD | -5116.046% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1877.472% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -287.547% |
| BioAtla, Inc. | 48.98 Million USD | -808.323% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4066.128% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -15911.191% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -240.687% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -3030.151% |
| XOMA Corporation | 145.58 Million USD | -205.64% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1221.702% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -547.117% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1308.206% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -619.718% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -889.55% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -819.282% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -15403.519% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -5354.156% |
| Akari Therapeutics, Plc | 4.58 Million USD | -9606.61% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2409.151% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 73.024% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -110061.472% |
| UroGen Pharma Ltd. | 243.52 Million USD | -82.714% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -38.576% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -16012.318% |
| Orgenesis Inc. | 35.53 Million USD | -1152.149% |
| Entera Bio Ltd. | 1.37 Million USD | -32166.207% |
| GH Research PLC | 6.7 Million USD | -6540.069% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -6443.397% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2263.492% |
| Xencor, Inc. | 283.55 Million USD | -56.917% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -14802.861% |
| Replimune Group, Inc. | 113.21 Million USD | -293.018% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -11742.859% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -329.78% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -110061.472% |
| Portage Biotech Inc. | 4.45 Million USD | -9898.899% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -29479.768% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1830.373% |
| OncoCyte Corporation | 49.29 Million USD | -802.574% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -10655.909% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -55694.348% |
| Purple Biotech Ltd. | 10 Million USD | -4347.286% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -7590.131% |
| scPharmaceuticals Inc. | 57.26 Million USD | -677.058% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3491.784% |
| HilleVax, Inc. | 78.9 Million USD | -463.879% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -8710.911% |
| Tharimmune, Inc. | 1.81 Million USD | -24414.585% |
| Genprex, Inc. | 3.25 Million USD | -13573.096% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1540.735% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -8397.918% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -215895.631% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -123998.029% |
| OKYO Pharma Limited | 7.42 Million USD | -5895.961% |
| Savara Inc. | 37.19 Million USD | -1096.362% |
| Curis, Inc. | 57.61 Million USD | -672.323% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1589.911% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1035.085% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -30713.781% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2037.235% |
| BeiGene, Ltd. | 2.23 Billion USD | 80.08% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1989.973% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -69.572% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1991.525% |
| Erasca, Inc. | 78.61 Million USD | -466.016% |
| bluebird bio, Inc. | 424.62 Million USD | -4.787% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -67805.325% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 76.458% |
| DBV Technologies S.A. | 42.8 Million USD | -939.605% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -67805.325% |
| Moderna, Inc. | 4.57 Billion USD | 90.268% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -6260.986% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -26769.022% |
| Molecular Templates, Inc. | 31.17 Million USD | -1327.452% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2506.626% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 24.341% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -257.376% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1521.719% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1120.515% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -699.768% |
| MacroGenics, Inc. | 154.2 Million USD | -188.541% |
| RenovoRx, Inc. | 4.46 Million USD | -9863.077% |
| Adicet Bio, Inc. | 37.12 Million USD | -1098.683% |
| Prime Medicine, Inc. | 60.78 Million USD | -632.068% |
| Aditxt, Inc. | 28.53 Million USD | -1459.505% |
| Adagene Inc. | 45.16 Million USD | -885.073% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -246136.047% |
| Quantum-Si incorporated | 26.63 Million USD | -1570.801% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 36.214% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -14524.817% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -287.045% |
| SciSparc Ltd. | 1.59 Million USD | -27796.614% |
| Vericel Corporation | 127.7 Million USD | -248.421% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -7895.678% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -421.276% |
| Generation Bio Co. | 171.63 Million USD | -159.25% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -3752.39% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -963.687% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -76.08% |
| Invivyd, Inc. | 51.71 Million USD | -760.424% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -383.763% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -6739.874% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -489.37% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -43479.922% |
| 2seventy bio, Inc. | 310.12 Million USD | -43.474% |
| ADMA Biologics, Inc. | 193.97 Million USD | -129.385% |
| Clene Inc. | 38.95 Million USD | -1042.335% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1131.43% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -73.149% |
| GeoVax Labs, Inc. | 3.51 Million USD | -12541.081% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -133.861% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -3553.229% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -124.358% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -3548.695% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -824.843% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -742.056% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -20.304% |
| Evaxion Biotech A/S | 17.61 Million USD | -2425.622% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -176.489% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -190.465% |
| Trevena, Inc. | 48.26 Million USD | -821.949% |
| Surrozen, Inc. | 8.14 Million USD | -5362.873% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1960.435% |
| Cingulate Inc. | 10.36 Million USD | -4194.535% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -16080.036% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1093.154% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -12306.204% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -3283.658% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -40.274% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1690.619% |
| Clearmind Medicine Inc. | 3.61 Million USD | -12225.485% |
| Kronos Bio, Inc. | 54.2 Million USD | -720.928% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -845.839% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1854.992% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2116.885% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1862.172% |
| ImmunityBio, Inc. | 1.09 Billion USD | 59.193% |
| Korro Bio, Inc. | 51.75 Million USD | -759.775% |
| Kineta, Inc. | 7.22 Million USD | -6061.05% |
| BioVie Inc. | 9.7 Million USD | -4486.117% |
| Codexis, Inc. | 49.94 Million USD | -790.864% |
| Celularity Inc. | 102.92 Million USD | -332.289% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -362.301% |
| Celcuity Inc. | 51.45 Million USD | -764.821% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -128798.822% |
| Cibus, Inc. | 206.11 Million USD | -115.873% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -947.56% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1589.324% |
| IN8bio, Inc. | 8.77 Million USD | -4972.401% |
| Kodiak Sciences Inc. | 213.59 Million USD | -108.319% |
| Annexon, Inc. | 47.11 Million USD | -844.333% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -396.924% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -361.702% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -3150.427% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 82.909% |
| Eyenovia, Inc. | 19.78 Million USD | -2149.468% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -151.263% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5692.879% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1746.346% |
| Arcellx, Inc. | 339.75 Million USD | -30.963% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3639.713% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -81.213% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -4552.839% |
| Moolec Science SA | 13.94 Million USD | -3090.675% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -931.125% |
| Geron Corporation | 146.12 Million USD | -204.496% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -780.533% |
| Royalty Pharma plc | 6.29 Billion USD | 92.935% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1018.642% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -151035.167% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -17985.366% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -135.23% |
| Humacyte, Inc. | 114.67 Million USD | -288.004% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1431.62% |
| 89bio, Inc. | 59.96 Million USD | -642.043% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1581.408% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -37103.261% |
| Genelux Corporation | 8.42 Million USD | -5184.454% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -6389.95% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -226.404% |
| Notable Labs, Ltd. | 4.42 Million USD | -9950.847% |
| Liquidia Corporation | 73.13 Million USD | -508.372% |
| Mustang Bio, Inc. | 17.61 Million USD | -2425.404% |
| Immunovant, Inc. | 48.95 Million USD | -808.898% |
| Quantum-Si incorporated | 26.63 Million USD | -1570.801% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1059.24% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -14239.381% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -502.417% |
| Acasti Pharma Inc. | 11.55 Million USD | -3750.056% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1868.137% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -16268.085% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1106.581% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -32548.759% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -7199.065% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1691.629% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1819.216% |
| PepGen Inc. | 34.63 Million USD | -1184.834% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3563.958% |
| United Therapeutics Corporation | 1.18 Billion USD | 62.362% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -6271.005% |
| Solid Biosciences Inc. | 38.45 Million USD | -1056.979% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5099.731% |
| Immuneering Corporation | 12 Million USD | -3605.345% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -141668.252% |
| Silo Pharma, Inc. | 1.56 Million USD | -28254.012% |
| Belite Bio, Inc | 4.21 Million USD | -10466.398% |
| XOMA Corporation | 145.58 Million USD | -205.64% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -18225.824% |
| Bionomics Limited | 10.15 Million USD | -4279.99% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1970.406% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1841.915% |
| uniQure N.V. | 624.01 Million USD | 28.696% |
| Cassava Sciences, Inc. | 14.19 Million USD | -3034.561% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -246136.047% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -161.453% |
| Forte Biosciences, Inc. | 3.66 Million USD | -12037.234% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -170652.121% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -6494.798% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5692.879% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2459.691% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -4110.361% |
| Altimmune, Inc. | 16.54 Million USD | -2589.989% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 27.967% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1841.915% |
| Compugen Ltd. | 55.77 Million USD | -697.761% |
| Peak Bio, Inc. | 20.75 Million USD | -2043.995% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -302.805% |
| Benitec Biopharma Inc. | 4.96 Million USD | -8867.17% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -181.895% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -491.895% |
| Zura Bio Limited | 21.29 Million USD | -1989.757% |
| PolyPid Ltd. | 17.46 Million USD | -2447.235% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -295.867% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -491.895% |
| Instil Bio, Inc. | 99.8 Million USD | -345.838% |
| Immunome, Inc. | 28.65 Million USD | -1452.624% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -5237.064% |
| Verona Pharma plc | 58.84 Million USD | -656.192% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2974.352% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2894.488% |
| CervoMed Inc. | 2.59 Million USD | -17041.54% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -9029.073% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3393.648% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -4123.55% |
| Moolec Science SA | 13.94 Million USD | -3090.675% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -18886.569% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -700.339% |
| AnaptysBio, Inc. | 364.28 Million USD | -22.143% |
| Design Therapeutics, Inc. | 11.95 Million USD | -3621.571% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3407.971% |
| NeurAxis, Inc. | 1.91 Million USD | -23162.505% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1043.01% |
| Lumos Pharma, Inc. | 13.33 Million USD | -3237.216% |
| Achilles Therapeutics plc | 19.08 Million USD | -2231.173% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2974.352% |
| 180 Life Sciences Corp. | 5.38 Million USD | -8159.397% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1786.346% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1854.992% |
| Nutriband Inc. | 1.07 Million USD | -41140.445% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1354.183% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2966.301% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -10.885% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1270.218% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -3309.822% |
| Palisade Bio, Inc. | 2.73 Million USD | -16145.016% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -8370.417% |
| Beam Therapeutics Inc. | 478.38 Million USD | 6.989% |
| Neurogene Inc. | 36.54 Million USD | -1117.41% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -11.81% |
| AEON Biopharma, Inc. | 159.88 Million USD | -178.287% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -833.79% |
| Sesen Bio, Inc. | 30.98 Million USD | -1336.067% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1613.921% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -5752.912% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -127.32% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -131.677% |
| Athira Pharma, Inc. | 30.05 Million USD | -1380.357% |
| Vaccinex, Inc. | 5.94 Million USD | -7388.236% |
| HCW Biologics Inc. | 15.05 Million USD | -2856.103% |
| XOMA Corporation | 145.58 Million USD | -205.64% |
| Nektar Therapeutics | 267.04 Million USD | -66.62% |
| Arvinas, Inc. | 644.6 Million USD | 30.973% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2409.151% |
| Merus N.V. | 102.15 Million USD | -335.582% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -204.032% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -367.779% |
| Rezolute, Inc. | 11.73 Million USD | -3691.981% |
| Clene Inc. | 38.95 Million USD | -1042.335% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -15526.681% |
| BeyondSpring Inc. | 48.26 Million USD | -821.815% |
| Synlogic, Inc. | 32.89 Million USD | -1252.64% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2944.898% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -27130.783% |
| Peak Bio, Inc. | 20.75 Million USD | -2043.995% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -601.163% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1020.388% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -18.136% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -346.877% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -102725.113% |
| MannKind Corporation | 721.36 Million USD | 38.318% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1892.169% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -21230.345% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -333.718% |
| Gossamer Bio, Inc. | 249.14 Million USD | -78.59% |
| CohBar, Inc. | 1.03 Million USD | -42947.082% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -4062.7% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2235.946% |
| Legend Biotech Corporation | 589.93 Million USD | 24.576% |
| Mural Oncology plc | 37.92 Million USD | -1073.146% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -235.468% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -19285.039% |
| Disc Medicine, Inc. | 22.87 Million USD | -1845.141% |
| Champions Oncology, Inc. | 28.03 Million USD | -1487.127% |
| REGENXBIO Inc. | 262.22 Million USD | -69.681% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -13145.144% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3449.952% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -3212.711% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1998.331% |
| Vaxart, Inc. | 34.02 Million USD | -1207.718% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2082.281% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1459.487% |
| Cellectis S.A. | 249.57 Million USD | -78.283% |
| Longeveron Inc. | 5.33 Million USD | -8237.099% |
| Repare Therapeutics Inc. | 41.81 Million USD | -963.992% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 81.501% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -637.064% |
| Revolution Medicines, Inc. | 262.39 Million USD | -69.572% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -21017.75% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -5058.254% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -3670.452% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -3068.49% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -20585.774% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 91.36% |
| Denali Therapeutics Inc. | 122.96 Million USD | -261.858% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -7895.678% |
| Veru Inc. | 32.81 Million USD | -1256.033% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -6377.668% |
| Cingulate Inc. | 10.36 Million USD | -4194.535% |
| Passage Bio, Inc. | 39.26 Million USD | -1033.287% |
| Context Therapeutics Inc. | 4.19 Million USD | -10515.011% |
| Exicure, Inc. | 8.54 Million USD | -5104.714% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1407.9% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -4143.286% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1918.742% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -173.0% |
| Nuvalent, Inc. | 31.82 Million USD | -1298.206% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -6894.296% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -606.025% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2371.95% |
| OmniAb, Inc. | 87.4 Million USD | -409.097% |
| Anew Medical, Inc. | 8.24 Million USD | -5298.712% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1062.083% |
| Lipocine Inc. | 2.63 Million USD | -16807.816% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1593.632% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1006.513% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1570.123% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -416.46% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -8138.308% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -437.725% |
| Ocugen, Inc. | 23.98 Million USD | -1755.277% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -858.801% |
| Q32 Bio Inc. | 233.12 Million USD | -90.861% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -4807.909% |
| Alumis Inc. Common Stock | 53.5 Million USD | -731.653% |
| Equillium, Inc. | 27.95 Million USD | -1491.555% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -115.377% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -7807.899% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -7155.068% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -182.821% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -540.835% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -4361.019% |
| Dominari Holdings Inc. | 4.63 Million USD | -9499.806% |
| Edesa Biotech, Inc. | 1.84 Million USD | -24060.624% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1404.891% |
| Bio-Techne Corporation | 744.34 Million USD | 40.222% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -252.858% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -29.175% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -996.614% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1436.592% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -381.757% |
| Nkarta, Inc. | 105.6 Million USD | -321.355% |
| BioCardia, Inc. | 4.59 Million USD | -9593.922% |
| Iterum Therapeutics plc | 32.66 Million USD | -1262.29% |